Abbott Laboratories (ABT) Amortization - Intangibles (2012 - 2026)

Abbott Laboratories has reported Amortization - Intangibles for 15 years, with the latest figure at $658.0 million in Q2 2026.

• Quarterly Amortization - Intangibles rose 56.67% year-over-year to $658.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.9 billion (up 8.28% YoY) and the FY2025 annual result came in at $1.7 billion, down 10.44% from the prior year.
• Amortization - Intangibles improved to $658.0 million in Q2 2026 per ABT's latest filing, from $422.0 million in the prior quarter.
• Over five years, Amortization - Intangibles peaked at $658.0 million in Q2 2026 and troughed at $420.0 million in Q1 2025.
• A 5-year average of $478.8 million and a median of $476.5 million in 2023 frame the typical range for Amortization - Intangibles.
• The sharpest annual moves came in 2025 and 2026: Amortization - Intangibles fell 11.02% in 2025, then soared 56.67% in 2026.
• Over 5 years, Amortization - Intangibles stood at $496.0 million in 2022, then decreased by 3.02% to $481.0 million in 2023, then slipped by 3.33% to $465.0 million in 2024, then slipped by 9.25% to $422.0 million in 2025, then surged by 55.92% to $658.0 million in 2026.
• According to Business Quant data, Amortization - Intangibles over the past three periods registered $658.0 million, $422.0 million, and $422.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.